KRAS and colorectal cancer: Thus, a recent study investigated the anti-tumor effects of a neutralizing anti-human progastrin antibody; one of these neutralizing antibodies was shown to inhibit cell proliferation and the migration/invasion of colorectal cancer cell lines to reduce the self-renewal of cancer stem cells and to increase chemosensitivity of colorectal cancer cells harboring KRAS mutations [456].